Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

But between shortages, high out of pocket costs and the need for weekly injections, the medication is not ... Metformin ...

In persons with type 1 or type 2 diabetes, hyperglycaemic emergencies can be precipitated by poor compliance with treatment, serious infections, omission or sudden cessation of insulin injections, ...

Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

General, Tedros Ghebreyesus, said there has been an increase in the number of diabetes cases over the past three decades.